Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SANGAMO THERAPEUTICS, INC | Director | Common Stock | 57.7K | $34.6K | $0.60 | Jun 4, 2024 | Direct |
SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50K | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 15, 2022 | 2 | $0 | 4 | Dec 19, 2022 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 15, 2022 | 0 | $0 | 3 | Dec 19, 2022 | Director |